Sleep Apnea Drug Candidate Developer Incannex to Acquire RLS Therapy Candidate Developer APIRx

Incannex Healthcare Limited (IHL), a clinical-stage pharmaceutical company developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs including a drug candidate for obstructive sleep apnea, has executed a term sheet with binding commercial terms to wholly acquire APIRx Pharmaceutical USA LLC. It is subject to shareholder approval. APIRx is a biotechnology … Read more